Changmao Biochemical Engineering Company Limited (0954.HK)
HKD 0.31
(1.67%)
HKD 0.31
(1.67%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 77.85 Million CNY | -18.11% |
| 2022 | 93.48 Million CNY | 21.36% |
| 2021 | 77.03 Million CNY | -6.02% |
| 2020 | 81.96 Million CNY | 14.99% |
| 2019 | 71.27 Million CNY | -6.22% |
| 2018 | 76 Million CNY | 11.96% |
| 2017 | 67.89 Million CNY | -11.58% |
| 2016 | 76.78 Million CNY | 7.17% |
| 2015 | 71.64 Million CNY | 8.2% |
| 2014 | 66.21 Million CNY | -19.9% |
| 2013 | 82.66 Million CNY | 13.92% |
| 2012 | 72.56 Million CNY | 21.5% |
| 2011 | 59.72 Million CNY | 9.93% |
| 2010 | 54.33 Million CNY | 49.6% |
| 2009 | 36.31 Million CNY | 13.88% |
| 2008 | 31.89 Million CNY | 15.59% |
| 2007 | 27.59 Million CNY | 5.58% |
| 2006 | 26.13 Million CNY | -21.57% |
| 2005 | 33.32 Million CNY | 48.52% |
| 2004 | 22.43 Million CNY | -41.95% |
| 2003 | 38.64 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 15.27 Million CNY | 0.0% |
| 2024 Q1 | 15.27 Million CNY | -63.47% |
| 2023 Q4 | 41.82 Million CNY | 0.0% |
| 2023 FY | 76.56 Million CNY | -18.11% |
| 2023 Q1 | 16.37 Million CNY | -34.04% |
| 2023 Q2 | 16.37 Million CNY | 0.0% |
| 2023 Q3 | 41.82 Million CNY | 155.38% |
| 2022 FY | 93.48 Million CNY | 21.36% |
| 2022 Q3 | 24.82 Million CNY | 18.8% |
| 2022 Q4 | 24.82 Million CNY | 0.0% |
| 2022 Q1 | 20.89 Million CNY | -30.61% |
| 2022 Q2 | 20.89 Million CNY | 0.0% |
| 2021 Q4 | 30.11 Million CNY | 0.0% |
| 2021 Q1 | 15.32 Million CNY | -37.34% |
| 2021 Q2 | 15.32 Million CNY | 0.0% |
| 2021 Q3 | 30.11 Million CNY | 96.57% |
| 2021 FY | 77.03 Million CNY | -6.02% |
| 2020 Q3 | 24.45 Million CNY | 65.55% |
| 2020 Q4 | 24.45 Million CNY | 0.0% |
| 2020 Q1 | 14.77 Million CNY | 11.04% |
| 2020 FY | 81.96 Million CNY | 14.99% |
| 2020 Q2 | 14.77 Million CNY | 0.0% |
| 2019 Q4 | 13.3 Million CNY | 0.0% |
| 2019 Q2 | 22.86 Million CNY | 0.0% |
| 2019 Q1 | 22.86 Million CNY | 52.74% |
| 2019 Q3 | 13.3 Million CNY | -41.83% |
| 2019 FY | 71.27 Million CNY | -6.22% |
| 2018 Q2 | 22.16 Million CNY | 0.0% |
| 2018 FY | 76 Million CNY | 11.96% |
| 2018 Q4 | 14.97 Million CNY | 0.0% |
| 2018 Q3 | 14.97 Million CNY | -32.44% |
| 2018 Q1 | 22.16 Million CNY | 18.26% |
| 2017 Q2 | 18.14 Million CNY | 0.0% |
| 2017 FY | 67.89 Million CNY | -11.58% |
| 2017 Q4 | 18.74 Million CNY | 0.0% |
| 2017 Q3 | 18.74 Million CNY | 3.27% |
| 2017 Q1 | 18.14 Million CNY | 6.68% |
| 2016 Q4 | 17.01 Million CNY | 0.0% |
| 2016 Q2 | 18.53 Million CNY | 0.0% |
| 2016 Q3 | 17.01 Million CNY | -8.22% |
| 2016 Q1 | 18.53 Million CNY | 22.96% |
| 2016 FY | 76.78 Million CNY | 7.17% |
| 2015 FY | 71.64 Million CNY | 8.2% |
| 2015 Q3 | 15.07 Million CNY | -12.25% |
| 2015 Q4 | 15.07 Million CNY | 0.0% |
| 2015 Q1 | 17.18 Million CNY | 31.01% |
| 2015 Q2 | 17.18 Million CNY | 0.0% |
| 2014 Q2 | 20.01 Million CNY | 0.0% |
| 2014 Q1 | 20.01 Million CNY | -0.48% |
| 2014 FY | 66.21 Million CNY | -19.9% |
| 2014 Q4 | 13.11 Million CNY | 0.0% |
| 2014 Q3 | 13.11 Million CNY | -34.49% |
| 2013 Q2 | 21.29 Million CNY | 8.13% |
| 2013 FY | 82.66 Million CNY | 13.92% |
| 2013 Q4 | 20.11 Million CNY | 0.0% |
| 2013 Q3 | 20.11 Million CNY | -5.53% |
| 2013 Q1 | 19.69 Million CNY | -36.08% |
| 2012 Q3 | 18.41 Million CNY | 217.43% |
| 2012 FY | 72.56 Million CNY | 21.5% |
| 2012 Q4 | 30.8 Million CNY | 67.32% |
| 2012 Q2 | 5.8 Million CNY | -66.86% |
| 2012 Q1 | 17.5 Million CNY | 3.2% |
| 2011 FY | 59.72 Million CNY | 9.93% |
| 2011 Q3 | 13.65 Million CNY | 22.56% |
| 2011 Q1 | 18.79 Million CNY | 12.49% |
| 2011 Q2 | 11.13 Million CNY | -40.75% |
| 2011 Q4 | 16.96 Million CNY | 24.26% |
| 2010 Q3 | 13.88 Million CNY | 11.89% |
| 2010 Q4 | 16.71 Million CNY | 20.37% |
| 2010 FY | 54.33 Million CNY | 49.6% |
| 2010 Q2 | 12.4 Million CNY | 0.0% |
| 2009 FY | 36.31 Million CNY | 13.88% |
| 2009 Q2 | 9.45 Million CNY | 0.0% |
| 2008 FY | 31.89 Million CNY | 15.59% |
| 2007 FY | 27.59 Million CNY | 5.58% |
| 2006 FY | 26.13 Million CNY | -21.57% |
| 2005 FY | 33.32 Million CNY | 48.52% |
| 2004 FY | 22.43 Million CNY | -41.95% |
| 2003 FY | 38.64 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Wai Chun Bio-Technology Limited | 35.87 Million HKD | -117.029% |
| Lee & Man Chemical Company Limited | 588.88 Million HKD | 86.779% |